Author:
Díaz-Cañestro Manuel,Periañez Leonor,Mulet Xavier,Martin-Pena M. Luisa,Fraile-Ribot Pablo A.,Ayestarán Ignacio,Colomar Asunción,Nuñez Belén,Maciá Maria,Novo Andrés,Torres Vicente,Asensio Javier,López-Causapé Carla,Delgado Olga,Pérez José Luis,Murillas Javier,Riera Melchor,Oliver Antonio
Funder
Ministerio de Economía, Industria y Competitividad, Gobierno de España
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference34 articles.
1. Nathwani D, Raman G, Sulham K, Gavaghan M, Menon V (2014) Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control 3:32
2. Bassetti M, Carnelutti A, Peghin M (2017) Patient specific risk stratification for antimicrobial resistance and possible treatment strategies in gram-negative bacterial infections. Expert Rev Anti-Infect Ther 15:55–65
3. Sader HS, Farrell DJ, Flamm RK, Jones RN (2014) Ceftolozane/tazobactam activity tested against aerobic gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012). J Inf Secur 69:266–277
4. Moya B, Zamoramo L, Juan C, Perez JL, Ge Y, Oliver A (2010) Activity of a new cephalosporin, CXA-101 (FR264295), against beta-lactamase-resistant Pseudomonas aeruginosa mutants selected in vitro after antipseudomonal treatment of intensive care unit patients. Antimicrob Agents Chemother 54:1213–1217
5. Moyá B, Beceiro A, Cabot G, Juan C, Zamorano L, Alberti S et al (2012) Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities. Antimicrob Agents Chemother 56:4771–4778
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献